Polypharmacy, the new epidemic;La polypharmacie: Une nouvelle épidémie

Revue Medicale Suisse

Volumn 12, Issue 518, 2016, Pages 942-947

  Neuner Jehle, Stefan ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DECISION MAKING; EPIDEMIC; HEALTH PRACTITIONER; HOSPITALIZATION COST; HUMAN; INTERPERSONAL COMMUNICATION; MORBIDITY; MORTALITY; POLYPHARMACY; PRIMARY MEDICAL CARE; COMORBIDITY; COST BENEFIT ANALYSIS; DOCTOR PATIENT RELATION; ECONOMICS; EMPATHY; PATIENT CARE PLANNING; PRIMARY HEALTH CARE; SWITZERLAND;

COMORBIDITY; COST-BENEFIT ANALYSIS; DECISION MAKING; EMPATHY; HUMANS; PATIENT CARE PLANNING; PHYSICIAN-PATIENT RELATIONS; POLYPHARMACY; PRIMARY HEALTH CARE; SWITZERLAND;

EID: 84969961914     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Haefeli W. Polypharmazie. Swiss Med Forum 2011;11:847-52.
2. Viktil K, et al. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacology 2006;63:187-94.
3. Lau DT, et al. Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Arch Intern Med 2005;165:68-74.
4. Frazier SC. Health outcomes and polypharmacy in elderly individuals : An integrated literature review. J Gerontol Nurs 2005;31:4-11.
5. Corsonello A, et al., On behalf of the Gruppo Italiano di Farmacovigilanza nell'Anziano (GIFA) investigators. Polypharmacy in elderly patients at discharge from the acute care hospital. Ther Clin Risk Manag 2007:3:197-203.
6. Hughes L, Mc Murdo M, Guthrie B. Guidelines for people not for diseases : The challenges of applying UK clinical guidelines to people with multimorbidity. Age Ageing 2013;42:62-9.
7. Budnitz DS, et al. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 2011;365:2002-12.
8. Zhang M, et al. Co-morbidity and repeat admission to hospital for adverse drug reactions in older adults. BMJ 2009;338:a2752.
9. Fick DM, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults - results of a US Consensus Panel of experts. Arch Intern Med 2003;163:2716-24.
10. Holt S, Schmiedl S, Thürmann PA. Potentiell inadäquate Medikation für altere Menschen : Die PRISCUS-Liste. Deutsches Ärzteblatt 2010;107:543-51. www.priscus. net
11. Hanlon JT, et al. A randomised, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 1996;100:428-37.
12. Garfinkel D, Mangin D. Feasability study of a systematic approach for discontinuation of multiple medications in older adults. Arch Intern Med 2010;170:1648-54.
13. Neuner-Jehle S, Krones T, Senn O. Systematic deprescribing in polymorbid patients is feasible and accepted). PRAXIS 2014;103:317-23.
14. Hasler S, et al. Effect of a patient-centered drug review on polypharmacy in primary care patients : Study protocol for a cluster-randomized controlled trial. Trials 2015;16:380.
15. Gallagher P, Ryan C. STOPP (screening tool of older person's prescriptions) and START (screening tool to alert doctors to right treatment). Consensus validation. Int J Clin Pharmacol Ther 2008;46:72-83.
16. Drenth-Van Maanen AC, et al. Prescribing optimization method for improving prescribing in elderly patients receiving polypharmacy : Results of application to case histories by general practitioners. Drugs Aging 2009;26:687-701.
17. Hausärztliche Leitlinie Multimedikation, Leitliniengruppe Hessen / Deutsche Gesellschaft für Allgemeinmedizin und familienmedizin, 2013, revised 2015. From : www.pmvforschungsgruppe.de/pdf/03-publikationen/multimedikation-ll.pdf
18. The Scottish Intercollegiate Guidelines Network (SIGN) polypharmacy guidance, March 2015 . From : www.sign.ac.uk
19. www.choosingwisely.org
20. Kuijpers MA, et al. The OLDY (Old people drugs and dysregulation) study group. Relationship between polypharmacy and underprescribing. Br J Clin Pharmacol 2008;65:130-3.
21. Barry PJ, Gallagher P. START (screening tool to alert doctors to the right treatment) - an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing 2007;36:632-8.
22. Lang PO, Boland B, Dalleur O. Prescription médicamenteuse inappropriée : les nouveaux critères STOPP / START. Rev Med Suisse 2015;11:2115-23.
23. Patterson SM, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev 2012;5:CD008165.
24. Patterson SM, et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev 2014;10:CD008165.
25. Lipska KJ, et al. Potential overtreatment of diabetes mellitus in older adults with tight glycemic control. JAMA Intern Med 2015;175:356-62.
26. Blom JW, et al. Changing prediction of mortality by systolic blood pressure with increasing age : The Rotterdam study. Age 2013;35:431-8.
27. www.mdcalc.com/cha2ds2-vasc-scorefor-atrial-fibrillation-stroke-risk
28. www.mdcalc.com/has-bled-score-formajor-bleeding-risk
29. Puhan MA, et al. Benefit-harm analysis and charts for individualized and prefe- rence-sensitive prevention : Example of low dose aspirin for primary prevention of cardiovascular disease and cancer. BMC Medicine 2015;13:250. Online-Rechner : www.benefit-harm-balance.com
30. Odden MC, et al. Cost-effectiveness and population impact of statins for primary prevention in adults aged 75 years or older in the United States. Ann Intern Med 2015;162:533-41.
31. Schuling J, et al. Deprescribing medication in very elderly patients with multimorbidity : The view of Dutch GPs. A qualitative study. BMC Fam Pract 2012;13:56.
32. Reeve E, et al. Patient barriers to and enablers of deprescribing : A systematic review. Drugs Aging 2013;30:793-807.
33. Scott IA, et al. Reducing inappropriate polypharmacy : The process of deprescribing.JAMA Intern Med 2015;175:827-34.
34. Fried TR, et al. Health outcome prioritization as a tool for decision making among older persons with multiple chronic conditions. Arch Intern Med2011;171:1856-8.
35. Hardisty J, et al. Interprofessional learning for medication safety. Clin Teach 2014;11:290-6.